Jul 14, 2026 06:21AM
Jul 14, 2026 06:04AM
Jul 14, 2026 06:02AM
Jun 17, 2026 04:21PM
Jun 17, 2026 04:21PM
Jun 17, 2026 12:36PM
Jun 17, 2026 11:09AM GSK receives FDA approval for oral antibiotic to treat UTIs
May 28, 2026 06:30AM
May 28, 2026 06:30AM
May 13, 2026 04:05PM
Mar 26, 2026 04:05PM
Dec 19, 2025 08:01AM
Dec 19, 2025 08:00AM
Nov 13, 2025 04:05PM Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
Oct 21, 2025 02:00AM
Oct 21, 2025 02:00AM
Oct 14, 2025 08:00AM
Aug 12, 2025 04:01PM
May 28, 2025 07:01AM
May 28, 2025 07:00AM
May 13, 2025 04:01PM Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
Apr 28, 2025 04:01PM
Apr 28, 2025 04:01PM
Mar 27, 2025 04:01PM
Jan 10, 2025 07:07AM
Jan 10, 2025 07:00AM
Nov 14, 2024 04:05PM
Oct 29, 2024 04:06PM Spero Therapeutics (SPRO) Reports SPR720 Phase 2a Interim Results, Provides a Business Update
Oct 29, 2024 04:05PM
Oct 16, 2024 04:06PM
Oct 16, 2024 04:05PM
Oct 2, 2024 04:31PM
Oct 2, 2024 04:30PM
Aug 5, 2024 04:01PM
Jul 3, 2024 01:05PM Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 3, 2024 04:05PM
May 16, 2024 04:05PM
May 15, 2024 04:05PM
May 8, 2024 08:00AM
May 1, 2024 04:07PM
Mar 13, 2024 04:01PM
Mar 6, 2024 08:05AM Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
Feb 28, 2024 08:05AM
Feb 28, 2024 08:05AM
Feb 26, 2024 08:05AM
Jan 31, 2024 04:05PM
Jan 5, 2024 08:05AM
Jan 5, 2024 08:05AM
Jan 2, 2024 08:05AM Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
Nov 13, 2023 04:05PM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All